Canada Healthcare Equipment & Supplies

Profound Medical Corp (PRN)

Track

Profound Medical Corp has seen no insider trading activity within the last three months. The most recent recorded transaction occurred on March 20, 2026, when a director and senior officer purchased shares. Historical data indicates a consistent pattern of buying by key executives and board members over the preceding periods.
Ticker: PRN Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Profound Medical Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
127.71
Quantity 67,445 +39.3%
Value US$3,087,647
2.5
Tamberrino, Thomas Michael Senior Officer of Issuer Officer
Transaction date
Purchase
Price
246.68
Quantity 76,275 +30.1%
Value US$2,506,853
2.5
Rosenthal, Arthur Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
353.21
Quantity 47,767 +19.0%
Value US$3,763,901
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
7.47
Quantity 13,396 +2.1%
Value US$100,001
2.5
Rosenthal, Arthur Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
4.93
Quantity 7,440 +21.3%
Value US$36,671
2.7
Menawat Arun Swarup CEO Executive Director
Transaction date
Purchase
Price
4.73
Quantity 12,027 +2.1%
Value US$56,888
2.5
Rosenthal, Arthur Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
4.77
Quantity 9,200 +35.9%
Value US$43,844
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
4.73
Quantity 12,027 +2.1%
Value US$56,888
2.7
Menawat Arun Swarup CEO Executive Director
Transaction date
Purchase
Price
4.33
Quantity 10,003 +1.8%
Value US$43,263
2.5
Tamberrino, Thomas Michael Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.14
Quantity 12,000 +90.0%
Value US$49,673
2.5
Rosenthal, Arthur Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
4.43
Quantity 8,360 +48.3%
Value US$37,024
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
4.33
Quantity 10,003 +1.8%
Value US$43,263
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
7.06
Quantity 14,200 +2.6%
Value US$100,224
2.5
Tamberrino, Thomas Michael Senior Officer of Issuer Officer
Transaction date
Purchase
Price
7.50
Quantity 13,333
Value US$99,998
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
7.50
Quantity 20,000 +3.7%
Value US$150,000
Goodman Abbey Officer Officer
Transaction date
Proposed sale
Price
8.11
Quantity 13,014
Value US$105,544
Jordan-Cornet Helen Spouse
Transaction date
Proposed sale
Price
7.49
Quantity 631
Value US$4,726
Jordan-Cornet Helen Spouse
Transaction date
Proposed sale
Price
7.49
Quantity 564
Value US$4,224
Jordan-Cornet Helen Member of immediate family of any of the foregoing
Transaction date
Proposed sale
Price
9.97
Quantity 22
Value US$219
Jordan-Cornet Helen Member of immediate family of any of the foregoing
Transaction date
Proposed sale
Price
9.97
Quantity 105
Value US$1,047
1.5
Dewan, Rashed Osman Senior Officer of Issuer Officer
Transaction date
Purchase
Price
12.85
Quantity 9,765 +41.1%
Value CA$125,480
1.4
Goodman, Abbey Klair Senior Officer of Issuer Officer
Transaction date
Sale
Price
8.06
Quantity 8,692
Value US$70,099
Goodman Abbey Officer Officer
Transaction date
Proposed sale
Price
8.06
Quantity 8,692
Value US$70,057
1.0
Burtnyk, Mathieu Senior Officer of Issuer Officer
Transaction date
Purchase
Price
14.15
Quantity 5,447 +67.2%
Value CA$77,090
1.0
Burtnyk, Mathieu Senior Officer of Issuer Officer
Transaction date
Purchase
Price
13.66
Quantity 3,000 +58.8%
Value CA$40,988
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
12.95
Quantity 24,558 +5.6%
Value CA$318,026
1.5
Dewan, Rashed Osman Senior Officer of Issuer Officer
Transaction date
Purchase
Price
12.95
Quantity 9,747 +69.6%
Value CA$126,224
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
17.41
Quantity 12,589 +3.0%
Value CA$219,174
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-20 2026-03-20 B Purchase
2.7
Menawat, Dr., Arun

Director of Issuer, Senior Officer of Issuer

Executive Director
67,445 +39.3%
127.71
US$3,087,647 		67,445 +39.3% 127.71 US$3,087,647
2025-12-24 2025-12-23 B Purchase
2.5
Tamberrino, Thomas Michael

Senior Officer of Issuer

Officer
76,275 +30.1%
246.68
US$2,506,853 		76,275 +30.1% 246.68 US$2,506,853
2025-12-23 2025-12-23 B Purchase
2.5
Rosenthal, Arthur Lee

Director of Issuer

Non-Executive Director
47,767 +19.0%
353.21
US$3,763,901 		47,767 +19.0% 353.21 US$3,763,901
2025-12-23 2025-12-23 B Purchase
2.7
Menawat, Dr., Arun

Director of Issuer, Senior Officer of Issuer

Executive Director
13,396 +2.1%
7.47
US$100,001 		13,396 +2.1% 7.47 US$100,001
2025-05-20 2025-05-19 B Purchase
2.5
Rosenthal, Arthur Lee

Director of Issuer

Non-Executive Director
7,440 +21.3%
4.93
US$36,671 		7,440 +21.3% 4.93 US$36,671
2025-05-20 2025-05-16 B Purchase
2.7
Menawat Arun Swarup

CEO

Executive Director
12,027 +2.1%
4.73
US$56,888 		12,027 +2.1% 4.73 US$56,888
2025-05-16 2025-05-16 B Purchase
2.5
Rosenthal, Arthur Lee

Director of Issuer

Non-Executive Director
9,200 +35.9%
4.77
US$43,844 		9,200 +35.9% 4.77 US$43,844
2025-05-16 2025-05-16 B Purchase
2.7
Menawat, Dr., Arun

Director of Issuer, Senior Officer of Issuer

Executive Director
12,027 +2.1%
4.73
US$56,888 		12,027 +2.1% 4.73 US$56,888
2025-05-20 2025-05-15 B Purchase
2.7
Menawat Arun Swarup

CEO

Executive Director
10,003 +1.8%
4.33
US$43,263 		10,003 +1.8% 4.33 US$43,263
2025-05-16 2025-05-15 B Purchase
2.5
Tamberrino, Thomas Michael

Senior Officer of Issuer

Officer
12,000 +90.0%
4.14
US$49,673 		12,000 +90.0% 4.14 US$49,673
2025-05-16 2025-05-15 B Purchase
2.5
Rosenthal, Arthur Lee

Director of Issuer

Non-Executive Director
8,360 +48.3%
4.43
US$37,024 		8,360 +48.3% 4.43 US$37,024
2025-05-16 2025-05-15 B Purchase
2.7
Menawat, Dr., Arun

Director of Issuer, Senior Officer of Issuer

Executive Director
10,003 +1.8%
4.33
US$43,263 		10,003 +1.8% 4.33 US$43,263
2025-03-18 2025-03-14 B Purchase
2.7
Menawat, Dr., Arun

Director of Issuer, Senior Officer of Issuer

Executive Director
14,200 +2.6%
7.06
US$100,224 		14,200 +2.6% 7.06 US$100,224
2024-12-11 2024-12-10 B Purchase
2.5
Tamberrino, Thomas Michael

Senior Officer of Issuer

Officer
13,333
7.50
US$99,998 		13,333 7.50 US$99,998
2024-12-10 2024-12-10 B Purchase
2.7
Menawat, Dr., Arun

Director of Issuer, Senior Officer of Issuer

Executive Director
20,000 +3.7%
7.50
US$150,000 		20,000 +3.7% 7.50 US$150,000
2024-11-12 2024-11-12 PrS Proposed sale
Goodman Abbey

Officer

Officer
13,014
8.11
US$105,544 		13,014 8.11 US$105,544
2024-09-23 2024-09-23 PrS Proposed sale
Jordan-Cornet Helen

Spouse
631
7.49
US$4,726 		631 7.49 US$4,726
2024-09-23 2024-09-18 PrS Proposed sale
Jordan-Cornet Helen

Spouse
564
7.49
US$4,224 		564 7.49 US$4,224
2024-08-30 2024-08-30 PrS Proposed sale
Jordan-Cornet Helen

Member of immediate family of any of the foregoing
22
9.97
US$219 		22 9.97 US$219
2024-08-27 2024-08-27 PrS Proposed sale
Jordan-Cornet Helen

Member of immediate family of any of the foregoing
105
9.97
US$1,047 		105 9.97 US$1,047
2024-08-16 2024-08-15 B Purchase
1.5
Dewan, Rashed Osman

Senior Officer of Issuer

Officer
9,765 +41.1%
12.85
CA$125,480 		9,765 +41.1% 12.85 CA$125,480
2024-03-27 2024-03-26 S Sale
1.4
Goodman, Abbey Klair

Senior Officer of Issuer

Officer
8,692
8.06
US$70,099 		8,692 8.06 US$70,099
2024-03-26 2024-03-26 PrS Proposed sale
Goodman Abbey

Officer

Officer
8,692
8.06
US$70,057 		8,692 8.06 US$70,057
2023-12-22 2023-12-05 B Purchase
1.0
Burtnyk, Mathieu

Senior Officer of Issuer

Officer
5,447 +67.2%
14.15
CA$77,090 		5,447 +67.2% 14.15 CA$77,090
2023-12-22 2023-09-26 B Purchase
1.0
Burtnyk, Mathieu

Senior Officer of Issuer

Officer
3,000 +58.8%
13.66
CA$40,988 		3,000 +58.8% 13.66 CA$40,988
2023-12-22 2023-08-15 B Purchase
2.7
Menawat, Dr., Arun

Director of Issuer, Senior Officer of Issuer

Executive Director
24,558 +5.6%
12.95
CA$318,026 		24,558 +5.6% 12.95 CA$318,026
2023-12-22 2023-08-15 B Purchase
1.5
Dewan, Rashed Osman

Senior Officer of Issuer

Officer
9,747 +69.6%
12.95
CA$126,224 		9,747 +69.6% 12.95 CA$126,224
2023-12-22 2023-05-21 B Purchase
2.7
Menawat, Dr., Arun

Director of Issuer, Senior Officer of Issuer

Executive Director
12,589 +3.0%
17.41
CA$219,174 		12,589 +3.0% 17.41 CA$219,174
Explore more

More insider trading research around Profound Medical Corp

More insider trades in Canada
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America